Evolus, Inc. (EOLS )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol EOLS
- Company Evolus, Inc.
- Price $7.59
- Changes Percentage 2.43
- Change 0.18
- Day Low $7.21
- Day High $7.8
- Year High $9.42
- Year Low $3.86
- Market Cap $409,945,825
- Price Avg 50 EMA (D) $6.5
- Price Avg 200 EMA (D) $5.88
- Exchange NASDAQ
- Volume 139,115
- Average Volume 834,242
- Open $7.28
- Previous Close $7.41
- EPS -0.44
- PE -14.28
- Earnings Announcement 2026-08-04 20:00:00
- Shares Outstanding $65,854,751
Company brief: EVOLUS, INC. (EOLS )
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Mr. David Moatazedi
- https://www.evolus.com
- US
- N/A
- 02-08-2018
- US30052C1071
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.